189 related articles for article (PubMed ID: 9058411)
21. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.
Stanwood GD; Lucki I; McGonigle P
J Pharmacol Exp Ther; 2000 Dec; 295(3):1232-40. PubMed ID: 11082460
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.
Wallace DR; Booze RM
Neurochem Res; 1997 Feb; 22(2):163-70. PubMed ID: 9016841
[TBL] [Abstract][Full Text] [Related]
23. Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brain.
Flietstra RJ; Levant B
Life Sci; 1998; 62(20):1825-31. PubMed ID: 9600324
[TBL] [Abstract][Full Text] [Related]
24. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
25. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of dopamine D3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography.
Hillefors-Berglund M; Von Euler G
Eur J Pharmacol; 1994 Aug; 261(1-2):179-83. PubMed ID: 8001642
[TBL] [Abstract][Full Text] [Related]
27. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
[TBL] [Abstract][Full Text] [Related]
28. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
29. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior.
Neisewander JL; Fuchs RA; Tran-Nguyen LT; Weber SM; Coffey GP; Joyce JN
Neuropsychopharmacology; 2004 Aug; 29(8):1479-87. PubMed ID: 15100700
[TBL] [Abstract][Full Text] [Related]
30. Regional CNS densities of monoamine receptors in alcohol-naive alcohol-preferring P and -nonpreferring NP rats.
McBride WJ; Chernet E; Russell RN; Wong DT; Guan XM; Lumeng L; Li TK
Alcohol; 1997; 14(2):141-8. PubMed ID: 9085714
[TBL] [Abstract][Full Text] [Related]
31. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
Cagnotto A; Parotti L; Mennini T
Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Foulon C; Kung MP; Kung HF
J Med Chem; 1993 May; 36(10):1499-500. PubMed ID: 8098771
[No Abstract] [Full Text] [Related]
33. Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats.
Giardino L
Brain Res; 1996 May; 720(1-2):235-8. PubMed ID: 8782918
[TBL] [Abstract][Full Text] [Related]
34. Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Vessotskie JM; Kung MP; Chumpradit S; Kung HF
Neuropharmacology; 1997 Jul; 36(7):999-1007. PubMed ID: 9257944
[TBL] [Abstract][Full Text] [Related]
35. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
[TBL] [Abstract][Full Text] [Related]
36. Postnatal ontogeny of dopamine D3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression.
Demotes-Mainard J; Henry C; Jeantet Y; Arsaut J; Arnauld E
Brain Res Dev Brain Res; 1996 Jul; 94(2):166-74. PubMed ID: 8836575
[TBL] [Abstract][Full Text] [Related]
37. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
Joyce JN
Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
[TBL] [Abstract][Full Text] [Related]
38. The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain.
Tremblay M; Rouillard C; Lévesque D
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):857-82. PubMed ID: 9723125
[TBL] [Abstract][Full Text] [Related]
39. Dopamine D1 and D2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking.
Bahk JY; Li S; Park MS; Kim MO
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1095-104. PubMed ID: 12452531
[TBL] [Abstract][Full Text] [Related]
40. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
